| 000 | 01848 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516034425.0 | ||
| 264 | 0 | _c20110812 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1471-4159 | ||
| 024 | 7 |
_a10.1111/j.1471-4159.2011.07292.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNevalainen, Nina | |
| 245 | 0 | 0 |
_aDopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia. _h[electronic resource] |
| 260 |
_bJournal of neurochemistry _cJul 2011 |
||
| 300 |
_a12-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApomorphine _xpharmacology |
| 650 | 0 | 4 |
_aCorpus Striatum _xpathology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopa Decarboxylase _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xpathology |
| 650 | 0 | 4 |
_aElectrochemistry _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFunctional Laterality _xdrug effects |
| 650 | 0 | 4 |
_aLevodopa _xtoxicity |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aPotassium Chloride _xpharmacology |
| 650 | 0 | 4 |
_aPresynaptic Terminals _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin Plasma Membrane Transport Proteins _xmetabolism |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aStereotyped Behavior _xdrug effects |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 700 | 1 | _aAf Bjerkén, Sara | |
| 700 | 1 | _aLundblad, Martin | |
| 700 | 1 | _aGerhardt, Greg A | |
| 700 | 1 | _aStrömberg, Ingrid | |
| 773 | 0 |
_tJournal of neurochemistry _gvol. 118 _gno. 1 _gp. 12-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1471-4159.2011.07292.x _zAvailable from publisher's website |
| 999 |
_c20799106 _d20799106 |
||